Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000050

Chief Scientific Officer gave up 1,756 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan Chief Scientific Officer 2024-09-03 Shares withheld for taxes −469 $15.76 $7,392 188,345 D: show line 1 in the form
Sethuraman Natarajan Chief Scientific Officer 2024-09-03 Shares withheld for taxes −151 $16.93 $2,556 188,194 D: show line 2 in the form
Sethuraman Natarajan Chief Scientific Officer 2024-09-03 Shares withheld for taxes −14 $17.70 $248 188,180 D: show line 3 in the form
Sethuraman Natarajan Chief Scientific Officer 2024-09-04 Shares withheld for taxes −955 $15.42 $14,729 187,225 D: show line 4 in the form
Sethuraman Natarajan Chief Scientific Officer 2024-09-05 Shares withheld for taxes −167 $15.13 $2,526 187,058 D: show line 5 in the form
Loading xslF345X05/wk-form4_1725576454.xml…